<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article article-type="research-article" xml:lang="EN" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Pigment Cell Melanoma Res</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-id journal-id-type="nlm-id">101318927</journal-id><journal-title-group><journal-title>Pigment cell &amp; melanoma research</journal-title></journal-title-group><issn pub-type="ppub">1755-1471</issn><issn pub-type="epub">1755-148X</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2709973</article-id><article-id pub-id-type="pmcid-ver">PMC2709973.1</article-id><article-id pub-id-type="pmcaid">2709973</article-id><article-id pub-id-type="pmcaiid">2709973</article-id><article-id pub-id-type="manuscript-id">NIHMS97222</article-id><article-id pub-id-type="pmid">19226313</article-id><article-id pub-id-type="doi">10.1111/j.1755-148X.2009.00550.x</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS97222</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA97222</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Long-Lasting Pigmentation (LLP) of Human Skin, a New Look at an Overlooked Response to UV</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Coelho</surname><given-names initials="SG">Sergio G.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhou</surname><given-names initials="Y">Yanchun</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bushar</surname><given-names initials="HF">Harry F.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Miller</surname><given-names initials="SA">Sharon A.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zmudzka</surname><given-names initials="BZ">Barbara Z.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hearing</surname><given-names initials="VJ">Vincent J.</given-names></name><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Beer</surname><given-names initials="JZ">Janusz Z.</given-names></name><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1</label> Laboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892 USA</aff><aff id="A2"><label>2</label> Center for Devices and Radiological Health, US Food and Drug Administration, Silver Spring, MD, 20993 USA</aff><author-notes><corresp id="FN1">Address Correspondence to: Sergio G. Coelho, Pigment Cell Biology Section, Laboratory of Cell Biology, Building 37 Rm 2132, National Institutes of Health, Bethesda, MD 20892 USA, Phone: (301) 594-9645, Fax: (301) 402-8787, E-mail: <email>coelhos@mail.nih.gov</email></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>2</month><year>2009</year></pub-date><pub-date pub-type="ppub"><month>4</month><year>2009</year></pub-date><volume>22</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">180113</issue-id><fpage>238</fpage><lpage>241</lpage><pub-history><event event-type="nihms-submitted"><date><day>26</day><month>02</month><year>2009</year></date></event><event event-type="pmc-release"><date><day>01</day><month>04</month><year>2010</year></date></event><event event-type="pmc-live"><date><day>01</day><month>04</month><year>2010</year></date></event><event event-type="pmc-released-under-embargo"><date><day>14</day><month>07</month><year>2009</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-06 10:48:32.067"><day>06</day><month>06</month><year>2024</year></date></event></pub-history><permissions><license><license-p>This file is available for text mining. It may also be used consistent with the principles of fair use under the copyright law.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms97222.pdf"/><kwd-group><kwd>long-lasting pigmentation</kwd><kwd>melanogenesis</kwd><kwd>ultraviolet radiation</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><p id="P1">Dear Sir,</p><p id="P2">Induction of melanogenesis by ultraviolet radiation (UV) is a relatively slow process (<xref ref-type="bibr" rid="R11">Tadokoro et al., 2003</xref>; <xref ref-type="bibr" rid="R12">Tadokoro et al., 2005</xref>; <xref ref-type="bibr" rid="R13">Yamaguchi et al., 2008</xref>). UV-induces immediate pigment darkening (within minutes, remaining for hours) (<xref ref-type="bibr" rid="R4">Honigsmann et al., 1986</xref>; <xref ref-type="bibr" rid="R9">Routaboul et al., 1999</xref>), persistent pigment darkening (within hours, remaining for days) (<xref ref-type="bibr" rid="R5">Moyal et al., 2000</xref>; <xref ref-type="bibr" rid="R6">Moyal et al., 2006</xref>), and delayed pigmentation (within in days, remaining for weeks) (<xref ref-type="bibr" rid="R7">Ortonne, 1990</xref>; <xref ref-type="bibr" rid="R11">Tadokoro et al., 2003</xref>; <xref ref-type="bibr" rid="R12">Tadokoro et al., 2005</xref>; <xref ref-type="bibr" rid="R14">Young, 2006</xref>).</p><p id="P3">The majority of humans lose UV-induced pigmentation (tan) within a relatively short time, however a significant segment of the population maintains such pigmentation for many months. However, no systematic studies of long-lasting pigmentation (LLP) have been reported. Anecdotally, people know that pigmentation persists after UV exposure as “tan lines”, but the mechanism of this extended pigmentary response has not been elucidated. A literature search revealed only one study reporting pigmentation remaining 6 months after exposure to two minimal erythema doses (MED)(<xref ref-type="bibr" rid="R10">Suh <italic toggle="yes">et al.</italic>, 2007</xref>).</p><p id="P4">We analyzed the persistence of UV-induced pigmentation in humans of different complexion (<xref rid="F1" ref-type="fig">Figure 1</xref>) and analyzed factors that may predispose to LLP. We explored parameters that included gender, age, eye color, hair color, MED, minimal melanogenic dose (MMD), phototype, race/ethnicity, and constitutive pigmentation. <xref rid="F2" ref-type="fig">Figure 2</xref> shows that virtually all subjects exposed to ≥2 MED developed early pigmentation with a grade of ≥1 on a scale 0–4 (<xref rid="SD1" ref-type="supplementary-material">Table S1</xref>). A proportion of these subjects showed a pigmentation grade ≥1 at ≥9 months post-exposure. LLP+ subjects typically develop a strong pigmentation within days after UV exposure. This pigmentation remains robust on post-exposure day 16 (<xref rid="F1" ref-type="fig">Figure 1</xref>). Induction of LLP depends on the UV exposure level: only a few our subjects developed LLP after 1 MED, but at 2 MED the proportion of LLP+ subjects was substantial, and it increased with increasing UV dose.</p><p id="P5">Correlations between LLP+ occurrence and the three MED ranges, as defined in <xref rid="SD1" ref-type="supplementary-material">Appendix S1</xref>, were pronounced (<xref rid="T1" ref-type="table">Table 1</xref> and <xref rid="F3" ref-type="fig">Figure 3A</xref>). No subjects with MED &lt;299 J/m<sup>2</sup> showed LLP after exposure to &lt;2 MED. Subjects in the higher MED ranges exposed to &gt;2 MED showed LLP frequency of 40–70%. The “Unequally Spaced Repeated Measures Linear Model” (<xref rid="SD1" ref-type="supplementary-material">Appendix S1</xref>) demonstrated a statistically significant difference from zero, with p&lt;0.0001, for the independent variable MED. <xref rid="F3" ref-type="fig">Figure 3B</xref> shows frequency of LLP+ subjects in three MMD ranges (<xref rid="SD1" ref-type="supplementary-material">Appendix S1</xref>). Subjects with higher MMD values were more likely to develop LLP than those with lower MMD values, with statistically significant difference from zero and p=0.0001. The LLP+ response increased linearly with increasing age, over all ages (statistically significant difference from zero in predicting LLP, p&lt;0.005). Hence, LLP depends more on MED or MMD than on increasing age. One might expect that propensity to LLP correlates with constitutive pigmentation, phototype, or race/ethnicity. However, we found no statistically significant effect of these parameters on the frequency of the LLP occurrence. The melanin content expressed in mg eumelanin per ml was not always higher in LLP+ than in LLP- subjects, and showed considerable variability (<xref rid="T1" ref-type="table">Table 1</xref>).</p><p id="P6">Photographs of the study areas on the backs of subjects representing the six phototypes are shown in <xref rid="F1" ref-type="fig">Figure 1</xref>. Clearly, the LLP is more pronounced in darker phototypes but, with time, minimal perceptible pigmentation becomes harder to discern in the darker skin. Phototypes 1 and 2 showed the lowest, and phototypes 5 and 6 the highest tendency to be LLP+. LLP+ response occurred in all five racial/ethnic groups studied; however the number of subjects was too small to analyze the effects of race/ethnicity on predisposition to LLP.</p><p id="P7">Our observations indicate that after UV exposure humans can be divided into three classes: those who never develop pigmentation, those who develop pigmentation but lose it within 9 months and those who develop pigmentation that persists for at least 9 months (LLP). During that time, the pigmentation fades to varying degrees in different LLP+ subjects, nevertheless it remains visible. In our study, 32% of subjects showed LLP after ≥2 MED, while 61% had a LLP response after 4 MED. Our results are consistent with reports of LLP in Korean individuals (phototypes 3–5) up to 6 months after 2 MED (<xref ref-type="bibr" rid="R10">Suh <italic toggle="yes">et al.</italic>, 2007</xref>). High MED and MMD values are the best predictors of LLP. Also, advancing age may facilitate LLP induction. The relationship of race/ethnicity to LLP needs further evaluation in a larger cohort. We found no statistically significant indication that LLP is related to gender, eye color, hair color, phototype, or constitutive pigmentation (melanin content by reflectance spectroscopy). Clear correlations between MED or MMD with LLP and lack of correlation between phototype and propensity for LLP confirm our earlier conclusions regarding the superiority of MED as a human photosensitivity criterion (<xref ref-type="bibr" rid="R11">Tadokoro et al., 2003</xref>).</p><p id="P8">UV-induced pigmentation could remain visible for a long time if (1) desquamation of the epidermis is retarded or (2) the activity of the melanogenic system remains elevated. It is important to determine if any or both of these mechanisms (or still another process) is involved since benefits and risks of LLP are unknown and may be significant. On one hand, increased pigmentation may be photoprotective (<xref ref-type="bibr" rid="R13">Yamaguchi et al., 2008</xref>; <xref ref-type="bibr" rid="R14">Young, 2006</xref>). However, if prolonged activation of the melanogenic system is involved, there is potential risk of uncontrolled proliferation that might lead to melanoma (<xref ref-type="bibr" rid="R3">Gilchrest <italic toggle="yes">et al.</italic>, 1979</xref>). Further studies should help to define risks and benefits of LLP, and innovative approaches have been proposed (<xref ref-type="bibr" rid="R1">Aoki et al., 2007</xref>; <xref ref-type="bibr" rid="R8">Procaccini et al., 2007</xref>). Preliminary explorations in this area have just been reported (<xref ref-type="bibr" rid="R2">Brenner et al., 2009</xref>).</p><p id="P9">Better understanding of LLP should be sought to answer the following critical questions:</p><list id="L1" list-type="order"><list-item><p id="P10">Do any changes in the desquamation rate occur in the skin with LLP?</p></list-item><list-item><p id="P11">Is the spectrum of UV-activated melanogenic factors the same in LLP+ and LLP-skin?</p></list-item><list-item><p id="P12">Is the sequence of activation of melanogenic factors altered in skin with LLP?</p></list-item><list-item><p id="P13">How persistent is the activation of different melanogenic factors?</p></list-item></list><sec sec-type="supplementary-material" id="S1"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1" position="float" orientation="portrait"><label>Appendix S1</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS97222-supplement-Appendix_S1.doc" id="N0x1d23e40N0x2a215c0" position="anchor" mimetype="application" mime-subtype="msword" orientation="portrait"/></supplementary-material><supplementary-material content-type="local-data" id="SD2" position="float" orientation="portrait"><label>Suppl Figure 1</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHMS97222-supplement-Suppl_Figure_1.TIF" id="N0x1d23e40N0x2a21680" position="anchor" mimetype="text" mime-subtype="plain" orientation="portrait"/></supplementary-material></sec></body><back><sec id="S2" sec-type="display-objects"><title>Figures and Table</title><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>LLP ≥9 months after ultraviolet (UV) exposure in six phototypes (1 - Burns easily, never tans; 2 - Burns easily, tans slightly; 3 - Burns slightly, tans light brown; 4 -Burns slightly, tans moderate brown; 5 - Burns rarely, tans dark brown; 6 Never burns, tans black). The black squares show the areas with LLP, enlarged on the right side with doses in multiples of MED included. The subject numbers are given in parentheses.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" xlink:href="nihms97222f1.jpg" orientation="portrait"/></fig><fig id="F2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Pigmentation after 1–4 MED of UV.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" xlink:href="nihms97222f2.jpg" orientation="portrait"/></fig><fig id="F3" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Increasing MED, MMD, and frequency of LLP induction. <bold>(A)</bold> MED ranges, <bold>(B)</bold> MMD ranges - as defined in <xref rid="SD1" ref-type="supplementary-material">Appendix S1</xref>. Total number of subjects, 64; data for 62, 64, 60, 43, and 28 subjects at 1, 1.4, 2, 2.8, and 4 MED, respectively.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" xlink:href="nihms97222f3.jpg" orientation="portrait"/></fig><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>LLP Occurrence at Increasing Exposure Levels Sorted by Gender, MED range, MMD range, and the average constitutive melanin content (mg of eumelanin per ml).</p></caption><table frame="box" rules="cols"><thead><tr><th content-type="background-color:#C0C0C0" valign="bottom" rowspan="3" align="center" colspan="1">Multiple of MED Groups <xref rid="TFN1" ref-type="table-fn">1</xref></th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="3" colspan="1">LLP</th><th content-type="background-color:#C0C0C0" colspan="2" valign="top" align="center" rowspan="2">Gender</th><th content-type="background-color:#C0C0C0" colspan="3" valign="top" align="center" rowspan="1">MED Range (J/m<sup>2</sup>)</th><th content-type="background-color:#C0C0C0" colspan="3" valign="top" align="center" rowspan="1">MMD Range (J/m<sup>2</sup>) <xref rid="TFN2" ref-type="table-fn">2</xref></th><th content-type="background-color:#C0C0C0" valign="top" align="center" rowspan="1" colspan="1">Constitutive Pigmentation</th></tr><tr><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">Low</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">Med</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">High</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">Low</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">Med</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">High</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">Eumelanin (mg/ml)</th></tr><tr><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">Female</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">Male</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">&lt; 299</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">299–450</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">&gt; 450</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">&lt; 490</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">490–625</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">&gt; 625</th><th content-type="background-color:#C0C0C0" valign="bottom" align="center" rowspan="1" colspan="1">Mean ± SEM</th></tr></thead><tbody><tr><td colspan="11" align="center" valign="bottom" rowspan="1"><hr/>
</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.0 MED (n=62)</bold></td><td align="center" valign="top" rowspan="1" colspan="1">−</td><td align="center" valign="top" rowspan="1" colspan="1">37</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">20</td><td align="center" valign="top" rowspan="1" colspan="1">4.80 ± 0.71</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">+</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">6.51 ± 4.20</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">8%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">9%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">0%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">14%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">10%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">0%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">19%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">5%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1"/></tr><tr><td colspan="11" align="center" valign="bottom" rowspan="1"><hr/>
</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"><bold>1.4 MED (n=64)</bold></td><td align="center" valign="top" rowspan="1" colspan="1">−</td><td align="center" valign="top" rowspan="1" colspan="1">36</td><td align="center" valign="top" rowspan="1" colspan="1">21</td><td align="center" valign="top" rowspan="1" colspan="1">22</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">18</td><td align="center" valign="top" rowspan="1" colspan="1">19</td><td align="center" valign="top" rowspan="1" colspan="1">4.97 ± 0.78</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">+</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">0</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">1</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">4.14 ± 1.07</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">12%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">9%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">0%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">14%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">20%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">5%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">18%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">10%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1"/></tr><tr><td colspan="11" align="center" valign="bottom" rowspan="1"><hr/>
</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.0 MED (n=60)</bold></td><td align="center" valign="top" rowspan="1" colspan="1">−</td><td align="center" valign="top" rowspan="1" colspan="1">24</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">17</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">15</td><td align="center" valign="top" rowspan="1" colspan="1">5.01 ± 0.92</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">+</td><td align="center" valign="top" rowspan="1" colspan="1">16</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">5.11 ± 1.31</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">40%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">15%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">15%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">40%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">40%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">26%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">40%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">29%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1"/></tr><tr><td colspan="11" align="center" valign="bottom" rowspan="1"><hr/>
</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"><bold>2.8 MED (n=43)</bold></td><td align="center" valign="top" rowspan="1" colspan="1">−</td><td align="center" valign="top" rowspan="1" colspan="1">13</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">11</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">10</td><td align="center" valign="top" rowspan="1" colspan="1">5.11 ± 1.14</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">+</td><td align="center" valign="top" rowspan="1" colspan="1">14</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">6.87 ± 1.61</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">52%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">25%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">21%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">50%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">53%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">33%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">53%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">38%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1"/></tr><tr><td colspan="11" align="center" valign="bottom" rowspan="1"><hr/>
</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"><bold>4.0 MED (n=28)</bold></td><td align="center" valign="top" rowspan="1" colspan="1">−</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">6</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">3</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">2</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">5.79 ± 1.83</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1">+</td><td align="center" valign="top" rowspan="1" colspan="1">12</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">7</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">5</td><td align="center" valign="top" rowspan="1" colspan="1">8</td><td align="center" valign="top" rowspan="1" colspan="1">4</td><td align="center" valign="top" rowspan="1" colspan="1">5.71 ± 1.36</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">71%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">45%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">50%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">70%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">63%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">50%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">80%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1">50%</td><td align="center" valign="top" content-type="background-color:#C0C0C0" rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TFN1"><label>1</label><p>- The “n” refers to the number of subjects who received the specific dose out of total of 64 subjects.</p></fn><fn id="TFN2"><label>2</label><p>- Subject 7 was excluded here because they did not receive a dose large enough to produce a MMD value.</p></fn></table-wrap-foot></table-wrap></sec><ack id="S3"><p>This research was supported by the Office of Science and the Center for Devices and Radiological Health, Food and Drug Administration, and in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The authors wish to express their appreciation to Dr. Katalin S. Korossy and to Julia A. Kniskern, RN, for their dedication and critical contributions to this study.</p></ack><ref-list><ref id="R1"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aoki</surname><given-names>H</given-names></name><name name-style="western"><surname>Moro</surname><given-names>O</given-names></name><name name-style="western"><surname>Tagami</surname><given-names>H</given-names></name><name name-style="western"><surname>Kishimoto</surname><given-names>J</given-names></name></person-group><year>2007</year><article-title>Gene expression profiling analysis of solar lentigo in relation to immunohistochemical characteristics</article-title><source>Br J Dermatol</source><volume>156</volume><fpage>1214</fpage><lpage>1223</lpage><pub-id pub-id-type="pmid">17419692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2133.2007.07830.x</pub-id></element-citation></ref><ref id="R2"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brenner</surname><given-names>M</given-names></name><name name-style="western"><surname>Coelho</surname><given-names>SG</given-names></name><name name-style="western"><surname>Beer</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Miller</surname><given-names>SA</given-names></name><name name-style="western"><surname>Wolber</surname><given-names>R</given-names></name><name name-style="western"><surname>Smuda</surname><given-names>C</given-names></name><name name-style="western"><surname>Hearing</surname><given-names>VJ</given-names></name></person-group><year>2009</year><article-title>Long-Lasting Molecular Changes in Human Skin after Repetitive In Situ UV Irradiation</article-title><source>J Invest Dermatol</source><volume>129</volume><fpage>1002</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">18946495</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/jid.2008.325</pub-id><pub-id pub-id-type="pmcid">PMC2709208</pub-id></element-citation></ref><ref id="R3"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gilchrest</surname><given-names>BA</given-names></name><name name-style="western"><surname>Blog</surname><given-names>FB</given-names></name><name name-style="western"><surname>Szabo</surname><given-names>G</given-names></name></person-group><year>1979</year><article-title>Effects of aging and chronic sun exposure on melanocytes in human skin</article-title><source>J Invest Dermatol</source><volume>73</volume><fpage>141</fpage><lpage>143</lpage><pub-id pub-id-type="pmid">88488</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1523-1747.ep12581580</pub-id></element-citation></ref><ref id="R4"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Honigsmann</surname><given-names>H</given-names></name><name name-style="western"><surname>Schuler</surname><given-names>G</given-names></name><name name-style="western"><surname>Aberer</surname><given-names>W</given-names></name><name name-style="western"><surname>Romani</surname><given-names>N</given-names></name><name name-style="western"><surname>Wolff</surname><given-names>K</given-names></name></person-group><year>1986</year><article-title>Immediate pigment darkening phenomenon. A reevaluation of its mechanisms</article-title><source>J Invest Dermatol</source><volume>87</volume><fpage>648</fpage><lpage>652</lpage><pub-id pub-id-type="pmid">3772158</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1523-1747.ep12456326</pub-id></element-citation></ref><ref id="R5"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moyal</surname><given-names>D</given-names></name><name name-style="western"><surname>Chardon</surname><given-names>A</given-names></name><name name-style="western"><surname>Kollias</surname><given-names>N</given-names></name></person-group><year>2000</year><article-title>Determination of UVA protection factors using the persistent pigment darkening (PPD) as the end point. (Part 1) Calibration of the method</article-title><source>Photodermatol Photoimmunol Photomed</source><volume>16</volume><fpage>245</fpage><lpage>249</lpage><pub-id pub-id-type="pmid">11132126</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1034/j.1600-0781.2000.160602.x</pub-id></element-citation></ref><ref id="R6"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moyal</surname><given-names>D</given-names></name><name name-style="western"><surname>Wichrowski</surname><given-names>K</given-names></name><name name-style="western"><surname>Tricaud</surname><given-names>C</given-names></name></person-group><year>2006</year><article-title>In vivo persistent pigment darkening method: a demonstration of the reproducibility of the UVA protection factors results at several testing laboratories</article-title><source>Photodermatol Photoimmunol Photomed</source><volume>22</volume><fpage>124</fpage><lpage>128</lpage><pub-id pub-id-type="pmid">16719864</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0781.2006.00223.x</pub-id></element-citation></ref><ref id="R7"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ortonne</surname><given-names>JP</given-names></name></person-group><year>1990</year><article-title>The effects of ultraviolet exposure on skin melanin pigmentation</article-title><source>J Intl Med Res</source><volume>18</volume><fpage>8C</fpage><lpage>17C</lpage><pub-id pub-id-type="pmid">2227089</pub-id></element-citation></ref><ref id="R8"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Procaccini</surname><given-names>EM</given-names></name><name name-style="western"><surname>Napolitano</surname><given-names>A</given-names></name><name name-style="western"><surname>Panzella</surname><given-names>L</given-names></name><name name-style="western"><surname>Prizio</surname><given-names>E</given-names></name><name name-style="western"><surname>Monfrecola</surname><given-names>G</given-names></name></person-group><year>2007</year><article-title>Long-lasting pigmentation more than its intensity is a reliable indicator of skin sun resistance</article-title><source>Dermatology</source><volume>215</volume><fpage>173</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">17823511</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000106572</pub-id></element-citation></ref><ref id="R9"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Routaboul</surname><given-names>C</given-names></name><name name-style="western"><surname>Denis</surname><given-names>A</given-names></name><name name-style="western"><surname>Vinche</surname><given-names>A</given-names></name></person-group><year>1999</year><article-title>Immediate pigment darkening: description, kinetic and biological function</article-title><source>Eur J Dermatol</source><volume>9</volume><fpage>95</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">10066954</pub-id></element-citation></ref><ref id="R10"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Suh</surname><given-names>KS</given-names></name><name name-style="western"><surname>Roh</surname><given-names>HJ</given-names></name><name name-style="western"><surname>Choi</surname><given-names>SY</given-names></name><name name-style="western"><surname>Jeon</surname><given-names>YS</given-names></name><name name-style="western"><surname>Doh</surname><given-names>KS</given-names></name><name name-style="western"><surname>Bae</surname><given-names>JH</given-names></name><name name-style="western"><surname>Kim</surname><given-names>ST</given-names></name></person-group><year>2007</year><article-title>Long-term evaluation of erythema and pigmentation induced by ultraviolet radiations of different wavelengths</article-title><source>Skin Res Technol</source><volume>13</volume><fpage>154</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">17374056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0846.2007.00213.x</pub-id></element-citation></ref><ref id="R11"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tadokoro</surname><given-names>T</given-names></name><name name-style="western"><surname>Kobayashi</surname><given-names>N</given-names></name><name name-style="western"><surname>Zmudzka</surname><given-names>BZ</given-names></name><name name-style="western"><surname>Ito</surname><given-names>S</given-names></name><name name-style="western"><surname>Wakamatsu</surname><given-names>K</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Korossy</surname><given-names>KS</given-names></name><name name-style="western"><surname>Miller</surname><given-names>SA</given-names></name><name name-style="western"><surname>Beer</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Hearing</surname><given-names>VJ</given-names></name></person-group><year>2003</year><article-title>UV-induced DNA damage and melanin content in human skin differing in racial/ethnic origin</article-title><source>FASEB J</source><volume>17</volume><fpage>1177</fpage><lpage>1179</lpage><pub-id pub-id-type="pmid">12692083</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1096/fj.02-0865fje</pub-id></element-citation></ref><ref id="R12"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tadokoro</surname><given-names>T</given-names></name><name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Batzer</surname><given-names>J</given-names></name><name name-style="western"><surname>Coelho</surname><given-names>SG</given-names></name><name name-style="western"><surname>Zmudzka</surname><given-names>BZ</given-names></name><name name-style="western"><surname>Miller</surname><given-names>SA</given-names></name><name name-style="western"><surname>Wolber</surname><given-names>R</given-names></name><name name-style="western"><surname>Beer</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Hearing</surname><given-names>VJ</given-names></name></person-group><year>2005</year><article-title>Mechanisms of skin tanning in different racial/ethnic groups in response to ultraviolet radiation</article-title><source>J Invest Dermatol</source><volume>124</volume><fpage>1326</fpage><lpage>1332</lpage><pub-id pub-id-type="pmid">15955111</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.0022-202X.2005.23760.x</pub-id></element-citation></ref><ref id="R13"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yamaguchi</surname><given-names>Y</given-names></name><name name-style="western"><surname>Coelho</surname><given-names>SG</given-names></name><name name-style="western"><surname>Zmudzka</surname><given-names>BZ</given-names></name><name name-style="western"><surname>Takahashi</surname><given-names>K</given-names></name><name name-style="western"><surname>Beer</surname><given-names>JZ</given-names></name><name name-style="western"><surname>Hearing</surname><given-names>VJ</given-names></name><name name-style="western"><surname>Miller</surname><given-names>SA</given-names></name></person-group><year>2008</year><article-title>Cyclobutane pyrimidine dimer formation and p53 production in human skin after repeated UV irradiation</article-title><source>Exp Dermatol</source><volume>17</volume><fpage>916</fpage><lpage>924</lpage><pub-id pub-id-type="pmid">18363705</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0625.2008.00722.x</pub-id></element-citation></ref><ref id="R14"><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Young</surname><given-names>AR</given-names></name></person-group><year>2006</year><article-title>Acute effects of UVR on human eyes and skin</article-title><source>Prog Biophys Mol Biol</source><volume>92</volume><fpage>80</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">16600340</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pbiomolbio.2006.02.005</pub-id></element-citation></ref></ref-list></back></article></pmc-articleset>